Primary |
Ex-tobacco User |
74.5% |
Product Used For Unknown Indication |
16.8% |
Smoking Cessation Therapy |
6.8% |
Tobacco Abuse |
0.6% |
Vomiting |
0.6% |
Weight Decreased |
0.6% |
|
Drug Ineffective |
23.7% |
Drug Administration Error |
11.8% |
Vomiting |
10.8% |
Hypersensitivity |
7.5% |
Application Site Pruritus |
6.5% |
Palpitations |
4.3% |
Abnormal Dreams |
3.2% |
Application Site Pain |
3.2% |
Application Site Rash |
3.2% |
Nausea |
3.2% |
Nonspecific Reaction |
3.2% |
Application Site Erythema |
2.2% |
Application Site Swelling |
2.2% |
Dermatitis Contact |
2.2% |
Feeling Abnormal |
2.2% |
Headache |
2.2% |
Incorrect Route Of Drug Administration |
2.2% |
Initial Insomnia |
2.2% |
Product Quality Issue |
2.2% |
Rash |
2.2% |
|
Secondary |
Ex-tobacco User |
94.8% |
Product Used For Unknown Indication |
2.6% |
Smoking Cessation Therapy |
2.6% |
|
Drug Ineffective |
24.1% |
Vomiting |
10.3% |
Application Site Rash |
6.9% |
Drug Administration Error |
6.9% |
Overdose |
6.9% |
Application Site Scab |
3.4% |
Dyspnoea |
3.4% |
Irritability |
3.4% |
Nausea |
3.4% |
Nightmare |
3.4% |
Product Quality Issue |
3.4% |
Productive Cough |
3.4% |
Somnolence |
3.4% |
Tension |
3.4% |
Throat Irritation |
3.4% |
Tremor |
3.4% |
Vascular Injury |
3.4% |
Vision Blurred |
3.4% |
|
Concomitant |
Smoking Cessation Therapy |
75.0% |
Ex-tobacco User |
25.0% |
|
Fatigue |
33.3% |
Nicotine Dependence |
33.3% |
Sensitivity Of Teeth |
33.3% |
|